Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06931886

Pulmonary Hypertension Inspiratory Training

Effects of Inspiratory Muscle Strength Training on Pulmonary Hypertension: A Six Week Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
4 (estimated)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is examining the effects of six weeks of inspiratory muscle strength training (IMST) on outcomes related to pulmonary hypertension. This study leverages previous cardiopulmonary exercise test (CPET) results and a pre-existing upcoming CPET to examine the effects of IMST on cardiopulmonary pressures and exercise tolerance and ability.

Detailed description

PH is a condition characterized by abnormally high blood pressure in the lungs (i.e., pulmonary arterial pressure), which impacts heart function and reduces exercise tolerance. This study will assess whether six weeks of a breathing exercise called IMST can improve heart and lung function as well as exercise capacity for individuals with PH. For this study, patients will be asked to perform IMST for the six weeks prior to their next scheduled clinical standard of care assessment of their PH. The goal of this study is to determine whether IMST reduces pulmonary arterial pressure and improves exercise tolerance in individuals with PH. This study will be minimally invasive, as it simply adds a safe, well-tolerated, non-invasive respiratory training to the participants' standard of care and leverages their existing PH assessment data to evaluate the impact of IMST on PH.

Conditions

Interventions

TypeNameDescription
OTHERInspiratory Muscle Strength TrainingParticipants will be asked to inhale against a resistance. This resistance will be set to \~55% of their maximal inspiratory ability. Participants will complete 5 sets of 6 breaths (30 total) a day for 5 days a week for 6 weeks.

Timeline

Start date
2025-10-25
Primary completion
2026-05-01
Completion
2026-10-01
First posted
2025-04-17
Last updated
2025-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06931886. Inclusion in this directory is not an endorsement.